Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacific Biosciences of California

1.54
-0.1000-6.10%
Post-market: 1.53-0.0100-0.65%19:12 EDT
Volume:8.01M
Turnover:12.37M
Market Cap:462.13M
PE:-0.66
High:1.64
Open:1.63
Low:1.51
Close:1.64
Loading ...

TD Cowen Remains a Buy on Pacific Biosciences (PACB)

TIPRANKS
·
09 Apr

Pacific Biosciences Shares Rise After Outlook, Impending Layoffs

Dow Jones
·
09 Apr

Pacific Biosciences of California Sees Lower Q1 Revenue, Plans Job Cuts to Reduce Costs

MT Newswires Live
·
09 Apr

BUZZ-PacBio rises on strong preliminary Q1 revenue, layoff plan

Reuters
·
09 Apr

BRIEF-Pacbio posts Preliminary Q1 2025 Revenue And Reiterates 2025 Revenue Guidance

Reuters
·
09 Apr

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

GlobeNewswire
·
09 Apr

Press Release: PacBio Grants Equity Incentive Award to New Employee

Dow Jones
·
05 Apr

Pacific Biosciences of California Names Jim Gibson CFO

MT Newswires Live
·
27 Mar

Pacific Biosciences Names Jim Gibson Chief Financial Officer

Dow Jones
·
27 Mar

BRIEF-Jim Gibson To Join PacBio As Chief Financial Officer

Reuters
·
27 Mar

Press Release: Jim Gibson to join PacBio as Chief Financial Officer

Dow Jones
·
27 Mar

Cathie Wood’s ARK Investment bought 899K shares of PacBio today

TIPRANKS
·
27 Mar

Pacific Biosciences Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
25 Mar

Scotiabank Keeps Their Buy Rating on Pacific Biosciences (PACB)

TIPRANKS
·
25 Mar

Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors

Zacks
·
21 Mar

Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading?

Insider Monkey
·
19 Mar

Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

GlobeNewswire
·
17 Mar

Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks

StockStory
·
17 Mar

Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know

Zacks
·
15 Mar

Bernstein Remains a Buy on Pacific Biosciences (PACB)

TIPRANKS
·
04 Mar